Editorial Roundup: Excerpts From Recent Editorials
Editorial Roundup: Excerpts From Recent Editorials in Newspapers in the US and Abroad
08:29PM 11/19/09
$5 Stocks That Crackle With Potential
By David Peltier | By Alix Steel
David Peltier, portfolio manager of Stocks Under $10, reveals three winners and how to trade them.
08:00AM 09/03/09
Biotech Calendar: Key FDA Action Dates
A quick and dirty guide to upcoming FDA approval dates for biotech drugs.
11:57AM 08/05/09
FDA Refuses to Approve Savient Gout Drug
The FDA has concerns that commercial supplies of Savient's Krystexxa are different from the drug that was used in clinical trials.
08:25PM 08/02/09
Biotech Calendar: Key FDA Action Dates
A quick and dirty guide to upcoming FDA approval dates for biotech drugs.
12:07PM 06/03/09
Swine Flu Daytrading (RealMoney.com $)
I expect this crisis to be over quick, but here are some ways to play it.
10:58AM 04/27/09
Five Dumbest Things on Wall Street: April 24
Apple's Asinine App; Kellogg Gets Bowled Over; Martha Stewart's CEO "Layer" Cake Collapses; Aubrey's Bailout Package;Stress Test Sham
08:39AM 04/24/09
Hollis-Eden Namesake Fired 'For Cause'
Hollis-Eden founder and CEO Richard Hollis was fired 'for cause' by his board, triggering a clause in his contract that strips him of millions of dollars in severance payments.
01:30AM 03/24/09
Genzyme Makes $24.5M Deal With Exact Sciences
Under the deal, Genzyme will own intellectual property related to prenatal and reproductive health.
01:04PM 01/28/09
A Look at Long-Term Care Costs
Most people preparing for retirement will need long-term care, though not many have planned for it.
11:34AM 12/02/08
Health Winners & Losers: Johnson & Johnson
The company won a favorable ruling in its patent case against Boston Scientific.
04:15PM 10/01/08
Advanced Life, Wyeth Ink Marketing Deal
Advanced Life Sciences completed antibiotic cethromycin's filing with U.S. regulators and signed an Asian marketing deal with Wyeth.
10:12AM 10/01/08
I Am Serious! (RealMoney Silver $)
This remains a market for only the most facile.
08:18AM 07/30/08
Biotech Defense Plays: Biogen, Genentech, Gilead, Onyx
In an ugly market, it's time to look at the sturdiest large-caps and mid-caps.
08:37AM 01/24/08



Connect with TheStreet